Advanced Filter

Filter by Group

Filter by Market Availability

Displaying drugs 14526 - 14550 of 15307 in total
Investigational
Investigational
Investigational
LG-100268 is a retinoid X receptor (RXR) selective compound.
Experimental
Experimental
Experimental
Reproxalap (previously ADX 102 or NS-2) is a small molecule inhibitor being developed by Aldeyra Therapeutics investigated against dry eye disease, allergic conjunctivitis, noninfectious anterior uveitis, and Sjögren-Larsson syndrome. NS-2 has orphan drug status due to it being investigated for treatment of Sjogren-Larsson syndrome.
Investigational
Matched Description: … Therapeutics investigated against dry eye disease, allergic conjunctivitis, noninfectious anterior uveitis, and
Experimental
Vet approved
Displaying drugs 14526 - 14550 of 15307 in total